The weekly litigation news digest is live. Subscribe now

IP Verse

Use Of Fertile Transgenic Animals For Producing Antibodies Bearing Human Variable Regions - EP2989894

The patent EP2989894 was granted to Kymab on Dec 14, 2022. The application was filed on Nov 30, 2012 under application number EP15188522A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP2989894

KYMAB
Application Number
EP15188522A
Filing Date
Nov 30, 2012
Status
Granted And Under Opposition
Jul 10, 2020
Publication Date
Dec 14, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
REGENERON PHARMACEUTICALSMay 11, 2021J A KEMPWITHDRAWN

Patent Citations (10) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
EXAMINATIONWO2013096142
OPPOSITIONWO02066630
OPPOSITIONWO2012141798
OPPOSITIONWO2013022782
OPPOSITIONWO2013096142
OTHERWO2013096142
SEARCHWO02066630
SEARCHWO2011004192
SEARCHWO2012141798
SEARCHWO2013022782

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents